Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 81

1.

Effect of Tocilizumab on Fatigue and Bone Mineral Density in Patients with Rheumatoid Arthritis.

Abu-Shakra M, Zisman D, Balbir-Gurman A, Amital H, Levy Y, Langevitz P, Tishler M, Molad Y, Aamar S, Roser I, Avshovich N, Paran D, Reitblat T, Mader R, Savin H, Friedman J, Lieberman N, Ehrlich S.

Isr Med Assoc J. 2018 Apr;20(4):239-244.

2.

Response to the letter to the editor by Gkougkourelas et al - EJCI-2017-0361.

Molad Y.

Eur J Clin Invest. 2017 Dec;47(12). doi: 10.1111/eci.12850. Epub 2017 Nov 7. No abstract available.

PMID:
29047115
3.

[IgG4-RELATED DISEASE].

Pokroy-Shapira E, Molad Y.

Harefuah. 2017 Jul;156(7):441-445. Review. Hebrew.

PMID:
28786269
4.

Corneal melting in rheumatoid arthritis patients treated with a tectonic reinforcing corneolimbal graft: an interventional case series.

Livny E, Mimouni M, Bahar I, Molad Y, Gershoni A, Kremer I.

Int Ophthalmol. 2017 Apr 21. doi: 10.1007/s10792-017-0545-z. [Epub ahead of print]

PMID:
28432580
5.

Authors' reply.

Furer V, Zisman D, Pokroy-Shapira E, Molad Y, Elkayam O, Paran D.

Scand J Rheumatol. 2017 May;46(3):251-252. doi: 10.1080/03009742.2016.1264628. Epub 2017 Feb 16. No abstract available.

PMID:
28276956
6.

Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss) Relapsing as Bullous Eruption.

Sherman S, Gal N, Didkovsky E, Molad Y, Pavlovsky L, Hodak E.

Acta Derm Venereol. 2017 Mar 10;97(3):406-407. doi: 10.2340/00015555-2570. No abstract available.

8.

Cutaneous Polyarteritis Nodosa Associated with Destructive Arthritis.

Atzmony L, Feuerman H, Molad Y, Didkovsky Y, Hodak E.

Isr Med Assoc J. 2015 Sep;17(9):587-8. No abstract available.

9.

Systemic lupus erythematosus exacerbation following cessation of belimumab treatment.

Furer V, Zisman D, Pokroy-Shapira E, Molad Y, Elkayam O, Paran D.

Scand J Rheumatol. 2016;45(2):103-6. doi: 10.3109/03009742.2015.1074277. Epub 2015 Oct 29.

PMID:
26515057
10.

Guanine polynucleotides are self-antigens for human natural autoantibodies and are significantly reduced in the human genome.

Fattal I, Shental N, Ben-Dor S, Molad Y, Gabrielli A, Pokroy-Shapira E, Oren S, Livneh A, Langevitz P, Zandman-Goddard G, Sarig O, Margalit R, Gafter U, Domany E, Cohen IR.

Immunology. 2015 Nov;146(3):401-10. doi: 10.1111/imm.12514. Epub 2015 Sep 7.

11.

Soluble triggering receptor expressed on myeloid cells-1 is a biomarker of anti-CCP-positive, early rheumatoid arthritis.

Molad Y, Ofer-Shiber S, Pokroy-Shapira E, Oren S, Shay-Aharoni H, Babai I.

Eur J Clin Invest. 2015 Jun;45(6):557-64. doi: 10.1111/eci.12442. Epub 2015 Apr 24.

PMID:
25832796
12.

Frequency of vascular and pregnancy morbidity in patients with low vs. moderate-to-high titers of antiphospholipid antibodies.

Ofer-Shiber S, Molad Y.

Blood Coagul Fibrinolysis. 2015 Apr;26(3):261-6. doi: 10.1097/MBC.0000000000000218.

PMID:
25526601
13.
14.

Acquired thrombasthenia due to inhibitory effect of glycoprotein IIbIIIa autoantibodies.

Blickstein D, Dardik R, Rosenthal E, Lahav J, Molad Y, Inbal A.

Isr Med Assoc J. 2014 May;16(5):307-10.

15.

Pemphigus vulgaris is characterized by low IgG reactivities to specific self-antigens along with high IgG reactivity to desmoglein 3.

Fattal I, Rimer J, Shental N, Molad Y, Gabrielli A, Livneh A, Sarig O, Goldberg I, Gafter U, Domany E, Cohen IR.

Immunology. 2014 Nov;143(3):374-80. doi: 10.1111/imm.12316.

16.

Association of low serum complement C3 with reduced patient and renal survival in antimyeloperoxidase-associated small-vessel vasculitis.

Molad Y, Tovar A, Ofer-Shiber S.

Nephron Clin Pract. 2014;126(1):67-74. doi: 10.1159/000357154. Epub 2014 Feb 27.

PMID:
24577364
17.

Evolution of chronic kidney disease in patients with systemic lupus erythematosus over a long-period follow-up: a single-center inception cohort study.

Pokroy-Shapira E, Gelernter I, Molad Y.

Clin Rheumatol. 2014 May;33(5):649-57. doi: 10.1007/s10067-014-2527-0. Epub 2014 Feb 19.

PMID:
24535410
18.

Increased ERK and JNK activation and decreased ERK/JNK ratio are associated with long-term organ damage in patients with systemic lupus erythematosus.

Bloch O, Amit-Vazina M, Yona E, Molad Y, Rapoport MJ.

Rheumatology (Oxford). 2014 Jun;53(6):1034-42.

PMID:
24501249
19.

Outcome of patients with rheumatoid arthritis: cross-sectional study of a single-center real-world inception cohort.

Ling E, Ofer-Shiber S, Goren O, Molad Y.

Isr Med Assoc J. 2013 Dec;15(12):758-62.

20.

Connective tissue disorders: systemic lupus erythematosus, Sjögren's syndrome, and scleroderma.

Streifler JY, Molad Y.

Handb Clin Neurol. 2014;119:463-73. doi: 10.1016/B978-0-7020-4086-3.00030-8. Review.

PMID:
24365313

Supplemental Content

Loading ...
Support Center